L. Zeng et al., EP4 EP2 RECEPTOR-SPECIFIC PROSTAGLANDIN E-2 REGULATION OF INTERLEUKIN-6 GENERATION BY HUMAN HSB.2 EARLY T-CELLS/, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1420-1426
Human leukemic early T cells of the HSB.2 line coexpress the EP2, EP3
and EP4 subtypes of prostaglandin E-2 (PGE(2)) receptors (Rs). EP, Rs
have previously been demonstrated to transduce PGE, stimulation of sec
retion of matrix metalloproteinase (MMP)-9 by HSB.2 T cells through Ca
++-dependent enhancement of MMP-9 mRNA transcription. We now show that
PGE(2) and the EP4/EP2/EP3 R-selective agonist misoprostol, but not t
he EP3 R-directed agonists sulprostone and M&B28767, induced increases
in HSB.2 T cell interleukin-6 (IL-6) mRNA and secretion. Pharmacologi
cal agents that increase intracellular concentration of cyclic AMP ([c
AMP](i)) mimicked and synergistically enhanced induction of IL-6 secre
tion by PGE(2), whereas inhibitors of protein kinase A (PKA) but not p
rotein kinase C suppressed PGE(2)-evoked increases in IL-6 secretion,
suggesting that cAMP and PKA are the intracellular messengers of the P
GE(2) effect. Exposure of HSB.2 T cells to the mitogenic lectin concan
avalin A (Con A) increased basal IL-6 secretion, without a change in I
L-6 mRNA level. Con A-stimulated HSB.2 T cells responded to PGE, with
greater increases in IL-6 mRNA and secretion of IL-6. Con A also down-
regulated mRNA encoding both EP3 Rs and EP2 Rs, and concurrently up-re
gulated mRNA encoding EP4 Rs of HSB.2 T cells. Therefore, EP4 and EP2
Rs mediate PGE(2)-induced increases in IL-6 secretion by HSB.2 T cells
through a transcriptional and cAMP dependent-mechanism. The increased
ratio of EP4 Rs/EP3 Rs may contribute to Con A enhancement of PGE(2)-
elicited increases in IL-6 secretion by HSB.2 T cells.